Publication | Open Access

Elevated level of peripheral CD8+CD28− T lymphocytes are an independent predictor of progression-free survival in patients with metastatic breast cancer during the course of chemotherapy

Progression-free SurvivalMetastatic Breast CancerBreast OncologyCancer ImmunosurveillanceMedicineIndependent PredictorImmunologyImmune RegulationImmune SurveillanceBreast CancerOncologyRadiation Oncology